The Hypolipidemic Activity of Boronated Nucleosides in Male Mice and Rats
Author Information
Author(s): Bruce S. Burnham, Anup Sood, Jeno Tomasz, W. J. Powell, Bernard F. Spielvogel, S. Y. Chen, Iris H. Hall
Primary Institution: University of North Carolina, Chapel Hill
Hypothesis
The study investigates the hypolipidemic effects of boronated nucleosides in rodents.
Conclusion
Boronated nucleosides significantly reduced cholesterol and triglyceride levels in mice and rats.
Supporting Evidence
- Boronated nucleosides reduced serum cholesterol levels by at least 40% by day 16.
- Serum triglyceride levels were reduced by greater than 30% on day 16.
- Compound 6 reduced serum cholesterol levels in rats by 36% and triglyceride levels by 32% after 14 days.
- Aorta wall cholesterol was reduced by 24% after administration of compound 6.
- Fecal triglycerides and phospholipids were significantly elevated after 14 days.
Takeaway
This study shows that certain boronated compounds can help lower bad fats in the body of mice and rats.
Methodology
The study involved administering boronated nucleosides to male mice and rats and measuring their serum cholesterol and triglyceride levels over a period of 14 to 16 days.
Limitations
The study was conducted only on rodents, and further research is needed to confirm the effects in humans.
Participant Demographics
Male CF1 mice and Sprague Dawley rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website